MarketLine Blog

Posts tagged to Healthcare

Medicaid: Trump’s budget proposal will not pass congress


It is that time of the year, when the White House is to put forward a proposal to congress underlying the US budget for FY2018 which is to set itself up for the next ten years. It is the first budget submission since Donald Trump took up presidency and there has already been speculation regarding his gloomy views on previous policy that aimed to benefit the less fortunate citizens of America. With the Affordable Care Act (nicknamed Obamacare) set up to help millions of Americans at potential danger of further… Read more

Pfizer re-entring to the OTC healthcare market


Pfizer Inc., the world’s largest pharmaceutical company, exited the over-the-counter (OTC) healthcare market in 2006 with the sale of its Consumer Healthcare division to Johnson & Johnson. Just 3 years later, in 2009, Pfizer re-entered the market with its acquisition of Wyeth. This article will examine the rise of Pfizer into a diversified healthcare company, the circumstances that led to the disposal of the Consumer Healthcare division, and the subsequent re-entry to the OTC market in 2009. Pfizer, Inc. was originally founded as fine chemicals business. Following a series of… Read more

Crest 3D White Using Consumer-Focused Innovation to Form a Point of Differentiation in a Saturated Teeth Whitening Market


An attractive smile – in particular white teeth – has become a sought-after physical attribute among today’s self-expressive and appearance-conscious US consumers. However, with today’s teeth whitening market nearing saturation in Western regions, it has become hard for industry players to achieve standout appeal. This blog entry examines how the Crest and Oral-B brands, which are both owned by Procter & Gamble, have used consumer-focused innovation to form a point of differentiation within the US teeth whitening market. The Crest and Oral-B 3D White Collection achieved $151.1m in first-year sales,… Read more

Manufacturers in Personal Care Market Adapting to Demands


Unit-dose packs have achieved wide acceptance in categories such as laundry detergents and pharmaceuticals, but progress has been slow in the personal care sector, despite opportunities to add value. This article analyzes the key consumer trends influencing demand for unit-dose packaging within the sector, and examines the extent to which consumer demand for convenience conflicts with concerns over price, performance, and over packaging. This article identifies the key consumer trends that impact upon demand for unit-dose packaging within the personal care sector. It identifies that: Unit-dose packs align well with… Read more

Remicade, a Biotech Blockbuster in Treating a Variety of Immune System Diseases


Remicade is a drug used in treating a variety of immune system diseases, and its active ingredient is produced through biotechnology.  Johnson & Johnson reported Remicade sales of $4.6 bn in 2010, and the drug is the best-selling “biologic” in the world. This article examines its long journey from an academic research laboratory to a leading position in the pharmaceutical market. In 2010, the world’s best-selling biologic drug was Remicade. Since its original US Food and Drug Administration (FDA) approval as a treatment for Crohn’s disease in 1998, global sales… Read more